Virology
Plasma as an alternative COVID-19 diagnostic specimen in a hospitalized patient negative for SARS-CoV-2 by nasopharyngeal swab

https://doi.org/10.1016/j.diagmicrobio.2021.115365Get rights and content

Highlights

  • Individuals with suspected COVID-19 and negative initial testing should undergo further testing.

  • Lower respiratory tract RNA testing by bronchoalveolar lavage may confirm the diagnosis.

  • Plasma RNA testing may serve as an adjunctive modality for confirmation of COVID-19 diagnosis.

Abstract

We present the case of an inpatient with pneumonia and repeatedly negative nasopharyngeal SARS-CoV-2 testing. In such challenging cases, alternative diagnostic options include lower respiratory tract and plasma SARS-CoV-2 RNA testing, of which the latter may be particularly useful where bronchoscopy is deferred due to clinical factors or transmission risk.

Keywords

plasma
RNA
SARS-CoV-2
COVID-19

Cited by (0)

View Abstract